The MURAL collection contains 33 adenocarcinomas from 19 patients, 18 neuroendocrine tumours from 7 patients, and 8 “mixed” tumours, which have both AR expression and neuroendocrine markers. This evidence concerns the gene AR and adenocarcinoma.